Back
Avenue Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
13
ATXI
Avenue Therapeutics
Last Price:
3.70
Seasonality Move:
-8.4%
Sell
37
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
1.9%
Sell
13
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy, Sell or Hold?
- The current Avenue Therapeutics [ATXI] share price is $3.65. The Score for ATXI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- ATXI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.10. The Score for NBY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATXI Stock Price Chart
What is Avenue Therapeutics's stock price today?
-
The Avenue Therapeutics share price today is $3.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
ATXI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.68 | Sell |
Relative Strength Index (14 RSI): | 25.48 | Sell |
Chaikin Money Flow: | -33204 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.07 - 9.39) | Sell |
Bollinger Bands (100): | (7.47 - 13.55) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 60.18 | Buy |
Chaikin Money Flow: | 10209132 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.07 - 0.09) | Buy |
Bollinger Bands (100): | (0.1 - 0.18) | Sell |
ATXI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.08 | Sell |
20-day SMA: | 5.91 | Sell |
50-day SMA: | 9.28 | Sell |
200-day SMA: | 26.03 | Sell |
8-day EMA: | 4.2 | Sell |
20-day EMA: | 5.71 | Sell |
50-day EMA: | 8.27 | Sell |
200-day EMA: | 39.06 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Buy |
20-day SMA: | 0.08 | Buy |
50-day SMA: | 0.1 | Buy |
200-day SMA: | 0.29 | Sell |
8-day EMA: | 0.09 | Buy |
20-day EMA: | 0.09 | Buy |
50-day EMA: | 0.11 | Sell |
200-day EMA: | 0.51 | Sell |
Avenue Therapeutics Earnings Growth & ATXI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Avenue Therapeutics Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |